Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of cultured myotonic dystrophy type 1 myoblasts treated with blocking or gapmer AONs

ABSTRACT: Antisense oligonucleotides (AONs) have gained momentum as therapeutics for neuromuscular disorders with the clinical approval of nusinersen and eteplirsen. For microsatellite repeat expansion disorders, AONs have not reached the clinic yet. Oligonucleotide therapies in such disorders are based on preventing translation of expanded repeats or sequestration of RNA-binding proteins. This can be achieved both by steric hindrance and by degradation of the transcript, and it is unknown which approach is superior. Here, we directly compared blocking AONs with RNase H-recruiting gapmers in a myotonic dystrophy type 1 cell model. Two target sequences were selected: the triplet repeat, which offers many identical binding sites, and a unique sequence upstream of the repeat. We performed RNA sequencing to investigate both on- and off-target effects on a transcriptome-wide level.

ORGANISM(S): Homo sapiens

PROVIDER: GSE130182 | GEO | 2023/05/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gapmer ASO targeting

Project description:Antisense oligonucleotides gapmers with multiple targets

| PRJEB53196 | ENA

Gene expression analysis in liver collected from mice administered non-toxic, toxic, or severely toxic LNA sequences

2014-01-08 | GSE53230 | GEO

Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

Project description:Triplet repeat siRNAs as found amplified in diseases such as Huntingtons disease can be used to kill cancer cells

2018-01-12 | GSE104552 | GEO

Gene expression analysis in liver collected from mice administered non-toxic, toxic, or severely toxic LNA sequences

Project description:Development of LNA gapmers, antisense oligonucleotides used for efficient inhibition of target RNA expression, is limited by non-target mediated hepatotoxicity issues. In the present study, we investigated hepatic transcription profiles of mice receiving non-toxic and toxic LNA gapmers after a single and repeat administration. To understand the mechanism of LNA gapmer-induced heptotoxicity in mice, we investigated the transcription profiles of liver RNA isolated from mice receiving non-toxic sequence (NTS-1), toxic sequence (TS-2), or severely toxic sequence (HTS-3) of LNA gapmers at 25 mg/kg (dose volume of 10 mL/kg) at 8, 16, or 72 hrs after a single administration (by subcutaneous injection ) using microarray analysis. We also investigated the transcription profiles of liver RNA isolated from mice receiving non-toxic sequence (NTS-1) or toxic sequence (TS-2) of LNA gapmers at 25 mg/kg (dose volume of 10 mL/kg) at 2 weeks after repeated administration (by subcutaneous injection ) using microarray analysis.

2014-01-08 | E-GEOD-53230 | biostudies-arrayexpress

RNA-dependent epigenetic silencing directs transcriptional down regulation caused by intronic repeat expansions

Project description:Transcriptional down regulation caused by intronic triplet repeat expansions underlies diseases such as Friedreich?s ataxia. This down regulation of gene expression is coupled with epigenetic changes but the underlying mechanisms are unknown. Here, we show that an intronic TTC/GAA triplet expansion within the IIL1 gene of Arabidopsis thaliana results in accumulation of 24-nt siRNAs and repressive histone marks at the IIL1 locus, which in turn causes its transcriptional down regulation and an associated phenotype. Knocking down DICER LIKE-3 (DCL3), which produces 24-nt siRNAs, suppressed transcriptional down regulation of IIL1 and the expansion-associated phenotype. Furthermore, knocking down additional components of the RNA-dependent DNA Methylation (RdDM) pathway, also suppressed both transcriptional down regulation of IIL1 and the repeat expansion associated phenotype. Thus our results show that triplet repeat expansions can lead to local siRNA biogenesis, which in turn down regulates transcription through an RdDM-dependent epigenetic modification.

2018-07-25 | GSE113923 | GEO

Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

Project description:Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

| PRJNA413038 | ENA

Effect of CWG-cPIP on CAG/CTG triplet repeat mouse brain

Project description:Effect of CWG-cPIP on CAG/CTG triplet repeat mouse brain

| PRJNA867693 | ENA

Effect of CWG-cPIP on transcriptome defects in CUG mouse brain

Project description:CWG-cPIP targets CAG/CTG (CWG) triplet repeat DNA to inhibit the transcription in a repeat length-dependent manner. To investigate effects of CWG-cPIP on transcriptome defects in the brain of CUG300 mice, which we developed as a model of DM1, CWG-cPIP (83 ug/kg) was injected into mouse hippocampus. RNA sequencing analysis was performed using mouse hippocampus 10 days later.

2023-10-11 | GSE210838 | GEO

Off-target effect of CWG-cPIP on gene expression of human fibroblasts

Project description:CWG-cPIP targets CAG/CTG (CWG) triplet repeat DNA to inhibit the transcription in a repeat length-dependent manner. To investigate off-target effects of CWG-cPIP on gene expression in cells, CWG-cPIP (1 μM) was treated to human fibroblasts. RNA sequencing analysis was performed using vehicle- or CWG-cPIP-treated human fibroblasts 7 days later, mixing with ERCC RNA spike-in controls.

2023-10-11 | GSE235810 | GEO

Off-target effect of CWG-cPIP on gene expression of mouse Striatum

Project description:CWG-cPIP targets CAG/CTG (CWG) triplet repeat DNA to inhibit the transcription in a repeat length-dependent manner. To investigate off-target effects of CWG-cPIP on gene expression in the brain, CWG-cPIP (664 ug/kg) was intracerebroventricularly injected into mouse. RNA sequencing analysis was performed using vehicle- or CWG-cPIP-injected mouse striatum 3 weeks later, mixing with ERCC RNA spike-in controls.

2023-10-11 | GSE235804 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data